
Eli Lilly and Company, UnitedHealth Group, and Thermo Fisher Scientific are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies whose primary business is healthcare and medicine — including pharmaceuticals, biotechnology, medical device and diagnostics manufacturers, hospitals, clinics and health insurers. Investors buy them for potential growth from drug approvals, new technologies and aging-population demand, while weighing sector-specific risks such as clinical trial failures, regulatory setbacks, patent expirations and reimbursement pressures. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read Our Latest Research Report on UNH
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Read Our Latest Research Report on TMO
Read More
- MarketBeat’s Top Five Stocks to Own in January 2026
- Why SanDisk Just Had One of the Biggest Days in Its History
- Starbucks’ Turnaround Makes a Strong Case for Long-Term Hold
- Crisis in the Caribbean: The Defense Sector Playbook
- Why Baidu’s Quiet Spin-Off Could Unlock a Major Re-Rating
- SailPoint Had a Week to Forget—Is This the Buying Window?
